Zofenopril-d5

Zofenopril-d5
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay43425-1 1 mg -

6 - 10 business days*

518.00€
 
Zofenopril-d5 is intended for use as an internal standard for the quantification of zofenopril... more
Product information "Zofenopril-d5"
Zofenopril-d5 is intended for use as an internal standard for the quantification of zofenopril (Cay-29525) by GC- or LC-MS. Zofenopril is a prodrug form of the angiotensin-converting enzyme (ACE) inhibitor zofenoprilat (Cay-38124). Zofenopril is hydrolyzed by cardiac esterases in vivo to form zofenoprilat. It inhibits ACE with an IC50 value of 0. nM in heart tissue homogenates and inhibits cardiac ACE activity in isolated perfused rat hearts. It reduces mean arterial blood pressure in two kidney-one clip renal hypertensive (2K-1C) rats and spontaneously hypertensive rats (SHRs) when administered at doses of 2. 6. and 22 mg/kg. Unlike the ACE inhibitor ramipril (Cay-15558), zofenopril does not affect bronchoalveolar lavage fluid (BALF) levels of bradykinin or prostaglandin E2 (PGE2, Cay-14010) or increase coughing induced by citric acid in guinea pigs.. Solulibility: DMSO: soluble: Methanol: soluble.
Keywords: (4S)-1-[(2S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-4-((phenyl-d5)thio)-L-proline
Supplier: Cayman Chemical
Supplier-Nr: 43425

Properties

Application: GC-MS, LC-MS, internal standard, ACE inhibitor
MW: 434.58 D
Formula: C22H18D5NO4S2
Purity: >99% deuterated forms (d1-d5)
Format: Solid

Database Information

KEGG ID : K01283 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Zofenopril-d5"
Write a review
or to review a product.
Viewed